Abstract
For a long time, the kidney has been considered incapable of regeneration. Instead, in recent years, studies have supported the existence of heterogeneity of renal stem/progenitor cells with the ability to regenerate both glomerular and tubular epithelial cells. Indeed, several studies evidence that renal progenitor cells, releasing chemokines, growth factors, microvesicles, and transcription factors through paracrine mechanisms, can induce tissue regeneration and block pathological processes of the kidney. In this chapter the potentiality of the kidney regenerative processes is considered and reviewed, and the main classes of stem/progenitor cells that might contribute to the renal tissue renewal is analyzed. Moreover, we evaluate the role of biomaterials in the regulation of cellular functions, specifically addressing renal stem/progenitor cells. Materials can be synthesized and tailored in order to recreate a finely structured microenvironment (by nanostructures, nanofibers, bioactive compounds, etc.) with which the cells can interact actively. For instance, by patterning substrates in regions that alternately promote or prevent protein adsorption, cell adhesion and spreading processes can be controlled in space. We illustrate the potentiality of nanotechnologies and engineered biomaterials in affecting and enhancing the behavior of renal stem/progenitor cells. Although there are still many challenges for the translation of novel therapeutics, advances in biomaterials and nanomedicine have the potential to drastically change the clinical and therapeutic landscape, even in combination with stem cell biology.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Remuzzi G, Benigni A, Remuzzi A (2006) Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest, 116:288-96. doi: https://doi.org/10.1172/JCI27699
Wiggins R-C (2007) The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int 71:1205–1214
Reimschuessel R (2001) A fish model of renal regeneration and development. ILAR J 42:285–291
Elger M, Hentschel H, Litteral J, Wellner M, Kirsch T, Luft FC, Haller H (2003) Nephrogenesis is induced by partial nephrectomy in the elasmobranch Leucoraja erinacea. J Am Soc Nephrol 14:1506–1518
Reimschuessel R, Bennett RO, May EB, Lipsky MM (1990) Development of newly formed nephrons in the goldfish kidney following hexachlorobutadiene-induced nephrotoxicity. Toxicol Pathol 18:32–38
Lazzeri E, Angelotti ML, Peired A et al (2018) Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury. Nat Commun 9:1344
Rinkevich Y, Montoro DT, Contreras-Trujillo H et al (2014) In vivo clonal analysis reveals lineage-restricted progenitor characteristics in mammalian kidney development, maintenance, and regeneration. Cell Rep 7:1270–1283
Schedl A (2007) Renal abnormalities and their developmental origin. Nat Rev Genet 8:791–802
Dressler GR (2006) The cellular basis of kidney development. Annu Rev Cell Dev Biol 22:509–529
Romagnani P, Lasagni L, Remuzzi G (2013) Renal progenitors: an evolutionary conserved strategy for kidney regeneration. Nat Rev Nephrol. https://doi.org/10.1038/nrneph.2012.290
Kobayashi A, Valerius MT, Mugford JW, Carroll TJ, Self M, Oliver G, McMahon AP (2008) Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 3:169–181
Kubota H, Avarbock MR, Brinster RL (2003) Spermatogonial stem cells share some, but not all, phenotypic and functional characteristics with other stem cells. Proc Natl Acad Sci 100:6487–6492
Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat M-L, Wu L, Lindeman GJ, Visvader JE (2006) Generation of a functional mammary gland from a single stem cell. Nature 439:84–88
Kozakowski N, Soleiman A, Pammer J (2008) BMI-1 expression is inversely correlated with the grading of renal clear cell carcinoma. Pathol Oncol Res 14:9–13
Rajasekhar VK, Begemann M (2007) Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective. Stem Cells 25:2498–2510
Pesce M, Schöler HR (2001) Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19:271–278
Imgrund M, Gröne E, Gröne HJ, Kretzler M, Holzman L, Schlöndorff D, Rothenpieler UW (1999) Re-expression of the developmental gene Pax-2 during experimental acute tubular necrosis in mice. Kidney Int 56:1423–1431. https://doi.org/10.1046/j.1523-1755.1999.00663.x
Lazzeri E, Crescioli C, Ronconi E et al (2007) Regenerative potential of embryonic renal multipotent progenitors in acute renal failure. J Am Soc Nephrol 18:3128–3138
Sallustio F, De Benedictis L, Castellano G, Zaza G, Loverre A, Costantino V, Grandaliano G, Schena FP (2010) TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J 24:514–525. https://doi.org/10.1096/fj.09-136481
Bussolati B, Bruno S, Grange C, Buttiglieri S, Deregibus MC, Cantino D, Camussi G (2005) Isolation of renal progenitor cells from adult human kidney. Am J Pathol 166:545–555
Baud L, Haymann JP, Bellocq A, Fouqueray B (2005) Contribution of stem cells to renal repair after ischemia/reperfusion. Bull Acad Natl Med 189:634–635
Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with Type 2 diabetes and nephropathy. N Engl J Med 345:861–869
Adamczak M, Gross M-L, Krtil J, Koch A, Tyralla K, Amann K, Ritz E (2003) Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J Am Soc Nephrol 14:2833–2842
Remuzzi A, Gagliardini E, Sangalli F, Bonomelli M, Piccinelli M, Benigni A, Remuzzi G (2006) ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease. Kidney Int 69:1124–1130
Gagliardini E, Corna D, Zoja C et al (2009) Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol 297:F1448–F1456
Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456–1462
Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M (1998) Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339:69–75
HISHIKAWA K, FUJITA T (2006) Stem cells and kidney disease. Hypertens Res 29:745–749
Hopkins C, Li J, Rae F, Little MH (2009) Stem cell options for kidney disease. J Pathol. https://doi.org/10.1002/path.2477
Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q (2004) The renal papilla is a niche for adult kidney stem cells. J Clin Invest. https://doi.org/10.1172/JCI20921
Little MH (2006) Regrow or repair: potential regenerative therapies for the kidney. J Am Soc Nephrol 17:2390–2401
Sagrinati C, Netti GS, Mazzinghi B et al (2006) Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys. J Am Soc Nephrol 17:2443–2456
Loverre A, Capobianco C, Ditonno P, Battaglia M, Grandaliano G, Schena FP (2008) Increase of proliferating renal progenitor cells in acute tubular necrosis underlying delayed graft function. Transplantation 85:1112–1119
Romagnani P (2009) Toward the identification of a “renopoietic system”? Stem Cells 27:2247–2253
Ronconi E, Sagrinati C, Angelotti ML et al (2009) Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol 20:322–332
Sallustio F, Serino G, Schena FP (2015) Potential reparative role of resident adult renal stem/progenitor cells in acute kidney injury. Biores Open Access 4:326–333
Sallustio F, Serino G, Costantino V, Curci C, Cox SN, De Palma G, Schena FP (2013) miR-1915 and miR-1225-5p regulate the expression of CD133, PAX2 and TLR2 in adult renal progenitor cells. PLoS One 10:e0128258. https://doi.org/10.1371/journal.pone.0068296
Procino G, Mastrofrancesco L, Sallustio F, Costantino V, Barbieri C, Pisani F, Schena FP, Svelto M, Valenti G (2011) AQP5 is expressed in type-B intercalated cells in the collecting duct system of the rat, mouse and human kidney. Cell Physiol Biochem 28:683–692. https://doi.org/10.1159/000335762
Benigni A, Morigi M, Rizzo P, Gagliardini E, Rota C, Abbate M, Ghezzi S, Remuzzi A, Remuzzi G (2011) Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 179:628–638
Angelotti ML, Ronconi E, Ballerini L et al (2012) Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30:1714–1725
Humphreys BD, Valerius MT, Kobayashi A, Mugford JW, Soeung S, Duffield JS, McMahon AP, Bonventre JV (2008) Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2:284–291
Sallustio F, Curci C, Aloisi A et al (2017) Inhibin-A and decorin secreted by human adult renal stem/progenitor cells through the TLR2 engagement induce renal tubular cell regeneration. Sci Rep 7:8225. https://doi.org/10.1038/s41598-017-08474-0
Castelletto L, Goya RG (1990) Sex-related incidence of tubular metaplasia in Bowman’s capsule of aging rats. Virchows Arch B Cell Pathol Incl Mol Pathol 59:79–82
Andrews PM (1981) The presence of proximal tubulelike cells in the kidney parietal epithelium in response to unilateral nephrectomy. Anat Rec 200:61–65
Langworthy M, Zhou B, de Caestecker M, Moeckel G, Baldwin HS (2009) NFATc1 identifies a population of proximal tubule cell progenitors. J Am Soc Nephrol 20:311–321
Walker B, Mouton CP (2006) Nanotechnology and nanomedicine: a primer. J Natl Med Assoc 98:1985–1988
Wagner V, Dullaart A, Bock AK, Zweck A (2006) The emerging nanomedicine landscape. Nat Biotechnol 24:1211–1217. https://doi.org/10.1038/nbt1006-1211
Caruthers SD, Wickline SA, Lanza GM (2007) Nanotechnological applications in medicine. Curr Opin Biotechnol 18:26–30. https://doi.org/10.1016/j.copbio.2007.01.006
Svenson S (2013) Theranostics: are we there yet? Mol Pharm 10:848–856
Lee DY, Li KCP (2011) Molecular theranostics: a primer for the imaging professional. Am J Roentgenol 197:318–324. https://doi.org/10.2214/AJR.11.6797
De Jong WH, Borm PJ a (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine, 3:133-149. doi: https://doi.org/10.2147/IJN.S596
Cho K, Wang X, Nie S, Chen ZG, Shin DM (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14:1310–1316. https://doi.org/10.1158/1078-0432.CCR-07-1441
Huang Y, Fan C-Q, Dong H, Wang S-M, Yang X-C, Yang S-M (2017) Current applications and future prospects of nanomaterials in tumor therapy. Int J Nanomed 12:1815–1825
Min Y, Caster JM, Eblan MJ, Wang AZ (2015) Clinical translation of nanomedicine. Chem Rev 115:11,147–11,190. https://doi.org/10.1021/acs.chemrev.5b00116
Caster JM, Patel AN, Zhang T, Wang A (2017) Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. https://doi.org/10.1002/wnan.1416
Li J, Mooney DJ (2016) Designing hydrogels for controlled drug delivery. Nat Rev Mater. https://doi.org/10.1038/natrevmats.2016.71
Peng E, Wang F, Xue JM (2015) Nanostructured magnetic nanocomposites as MRI contrast agents. J Mater Chem B 3:2241–2276. https://doi.org/10.1039/C4TB02023E
Wicki A, Witzigmann D, Balasubramanian V, Huwyler J (2015) Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release 200:138–157. https://doi.org/10.1016/j.jconrel.2014.12.030
Giancotti FG (1999) Integrin Signaling. Science. 285:1028–1032. https://doi.org/10.1126/science.285.5430.1028
Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673–687. https://doi.org/10.1016/S0092-8674(02)00971-6
Beningo KA, Dembo M, Wang Y -l. (2004) Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors. Proc Natl Acad Sci 101:18,024–18,029. https://doi.org/10.1073/pnas.0405747102
Ramakrishna S, Mayer J, Wintermantel E, Leong KW (2001) Biomedical applications of polymer-composite materials: a review. Compos Sci Technol 61:1189–1224. https://doi.org/10.1016/S0266-3538(00)00241-4
Daglar B, Ozgur E, Corman ME, Uzun L, Demirel GB (2014) Polymeric nanocarriers for expected nanomedicine: current challenges and future prospects. RSC Adv 4:48,639–48,659. https://doi.org/10.1039/c4ra06406b
de Las Heras Alarcon C, Pennadam S, Alexander C (2005) Stimuli responsive polymers for biomedical applications. Chem Soc Rev 34:276–285. https://doi.org/10.1039/b406727d
Gentile P, Chiono V, Carmagnola I, Hatton PV (2014) An overview of poly(lactic-co-glycolic) Acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci 15:3640–3659. https://doi.org/10.3390/ijms15033640
Tibbitt MW, Rodell CB, Burdick JA, Anseth KS (2015) Progress in material design for biomedical applications. Proc Natl Acad Sci 112:14,444–14,451. https://doi.org/10.1073/pnas.1516247112
Mahmoud Abbas AO (2010) Chitosan for biomedical applications. Univ Iowa. https://doi.org/10.3390/ma2020374
Mano JF (2008) Stimuli-responsive polymeric systems for biomedical applications. Adv Eng Mater 10:515–527. https://doi.org/10.1002/adem.200700355
Pařzek M, Novotná K, Bačáková L (2011) The role of smooth muscle cells in vessel wall pathophysiology and reconstruction using bioactive synthetic polymers. Physiol Res 60:419–437
Neyra MP. Interactions between titanium surfaces and biological components. PhD Thesis Dissertation 2009
Maheshwari G, Brown G, Lauffenburger DA, Wells A, Griffith LG (2000) Cell adhesion and motility depend on nanoscale RGD clustering. J Cell Sci 113:1677–1686. https://doi.org/10.1083/jcb.144.5.1019
DeLong SA, Gobin AS, West JL (2005) Covalent immobilization of RGDS on hydrogel surfaces to direct cell alignment and migration. J Control Release 109:139–148. https://doi.org/10.1016/j.jconrel.2005.09.020
Sciancalepore AG, Portone A, Moffa M, Persano L, De Luca M, Paiano A, Sallustio F, Schena FP, Bucci C, Pisignano D (2016) Micropatterning control of tubular commitment in human adult renal stem cells. Biomaterials 94:57–69. https://doi.org/10.1016/j.biomaterials.2016.03.042
Sciancalepore AG, Sallustio F, Girardo S, Passione LG, Camposeo A, Mele E, Lorenzo MD, Costantino V, Schena FP, Pisignano D (2014) A bioartificial renal tubule device embedding human renal stem/progenitor cells. PLoS One 10:e0128261. https://doi.org/10.1371/journal.pone.0087496
Khong TT, Aarstad OA, Skjåk-Bræk G, Draget KI, Vårum KM (2013) Gelling concept combining chitosan and alginate—proof of principle. Biomacromolecules 14:2765–2771
Sciancalepore AG, Moffa M, Iandolo D, Netti GS, Prattichizzo C, Grandaliano G, Lucarelli G, Cormio L, Gesualdo L, Pisignano D Aligned nanofiber topographies enhance the differentiation of adult renal stem cells into glomerular podocytes. Adv Eng Mater 20:1800003
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sallustio, F., Gesualdo, L., Pisignano, D. (2019). The Heterogeneity of Renal Stem Cells and Their Interaction with Bio- and Nano-materials. In: Birbrair, A. (eds) Stem Cells Heterogeneity - Novel Concepts. Advances in Experimental Medicine and Biology, vol 1123. Springer, Cham. https://doi.org/10.1007/978-3-030-11096-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-030-11096-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11095-6
Online ISBN: 978-3-030-11096-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)